5001842026-04-012026-06-305001842026-06-305001842026-04-012026-06-30in-capmkt:OtherExpenses1Member5001842026-04-012026-06-30in-capmkt:ReportableSegments1Member5001842026-04-012026-06-30in-capmkt:ReportableSegments2Member5001842026-04-012026-06-30in-capmkt:ReportableSegments1Member5001842026-04-012026-06-30in-capmkt:ReportableSegments2Member5001842026-04-012026-06-30in-capmkt:ReportableSegments1Member5001842026-06-30in-capmkt:ReportableSegments1Member5001842026-04-012026-06-30in-capmkt:ReportableSegments2Member5001842026-06-30in-capmkt:ReportableSegments2Member5001842026-04-012026-06-30in-capmkt:ReportableSegments1Member5001842026-06-30in-capmkt:ReportableSegments1Member5001842026-04-012026-06-30in-capmkt:ReportableSegments2Member5001842026-06-30in-capmkt:ReportableSegments2Member5001842026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15001842026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25001842026-06-30Statement15001842026-04-012026-06-30Statement15001842026-06-30StatementDynamic1I1Statement15001842026-06-30StatementDynamic1I2Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares500184HSCLNOTLISTEDINE019C01026Himadri Speciality Chemical LimitedMain BoardEquity2026-04-012027-03-312026-07-152026-07-08INRCroresQuarterlyFirst quarterMulti segment2026-07-1511:30:002026-07-1515:25:00Not applicabletrue1falseThere is no default in the payment of outstanding Loans / revolving facilities, Unlisted debt securities.2026-04-012026-06-30UnauditedStandalone1274260000058450000013327100000100239000000-1982200000420900000212200000192500000151910000010386400000294070000002940700000601500000105000000706500000022342000000000223420000031800000226600000050450000014.434.43004.434.43NOTES:- <br /> 1. The above unaudited standalone financial results have been reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 15 July 2026. A Limited Review of these standalone financial results for the quarter ended 30 June 2026 has been carried out by the Statutory Auditors, as required under Regulation 33 of SEBI (LODR) Regulations, 2015. <br /> 2. Other expenses includes foreign exchange fluctuation loss/ (gain) (net) of Rs 25.27 crores for the quarter ended 30 June 2026, Rs 38.33 crores for the quarter ended 31 March 2026, Rs (9.80) crores for the quarter ended 30 June 2025 and Rs 43.81 crores for the year ended 31 March 2026. <br /> 3. Based on the guiding principles given in Ind AS 108 on 'Operating Segments', the Company's business activity falls within two operating segments, namely: <br /> (a) Carbon materials and chemicals, and <br /> (b) Power <br /> 4. The Nomination and Remuneration Committee of the Company at its meeting held on 6 July 2026, has allotted 19,000 equity shares of Re 1 each (Under Grant II) to the option grantees pursuant to exercise of options under the Company’s “Himadri Employee Stock Option Plan 2016”. As a result of such allotment, the paid up equity share capital of the Company has increased from 50,45,41,599 equity shares to 50,45,60,599 equity shares of face value of Re 1 each. <br /> 5. The standalone figures for the three months ended 31 March 2026 as reported in these standalone financial results are the balancing figures between audited figures in respect of the full financial year and the published year to date standalone figures up to the end of the nine months of the relevant financial year. Also the standalone figures up to the third quarter had only been reviewed and not subjected to audit. <br /> 6. Earnings per share is not annualised for the quarter ended 30 June 2026, 31 March 2026 and 30 June 2025. <br /> Other Expenses1519100000Carbon materials and chemicals12651700000Power3188000001297050000022790000012742600000Carbon materials and chemicals2540100000Power2810000002821100000212200000-3318000002940700000Carbon materials and chemicals41739400000Power1017800000427572000002180980000064567000000Carbon materials and chemicals1928700000Power1070000019394000001453770000016477100000 Other unallocable expenses net of unallocable income includes other income and foreign exchange loss/ (gain) (net), fully unallocableRemeasurements of the net defined benefit plan-500000Net gain/ (loss) on investment in equity instruments accounted at fair value3750000037000000520000031800000Preferential Issues2025-11-1057000002026-06-30trueICRA LimitedfalseMonika SaraswatCompany Secretary and Compliance OfficerKolkata2026-07-15To Fund Capital expenditure for new green fields project or capital expenditure in its existing units and projects i.e. brown field expansion directly by the Company and/or through its subsidiaries or joint ventures or associates for the growth of existing businesses or to enter into new business in line with the strategy of the Company.Not Applicable2568200000018506000000The Compamy has not raised any amount through preferential issue or right issue or QIP or public issue during the quarter ended 30.06.2026. There are no warrants outstanding as on 30 June 2026. Since the fund received from preferential issue has not yet been fully utilized therefore as per Regulations 32 of the SEBI (LODR) Regulations, 2015, the Company is required to file Statement of Deviation during the quarter ended 30 June 2026 in XBRL mode along with integrated financial. To Fund General corporate purposes, which includes, inter alia, meeting ongoing general corporate exigencies and contingencies, expenses of the Company as applicable in such a manner and proportion as may be decided by the Board from time to time, and/or any other general purposes as may be permissible under applicable laws.Not Applicable85000000008287000000The Compamy has not raised any amount through preferential issue or right issue or QIP or public issue during the quarter ended 30.06.2026. There are no warrants outstanding as on 30 June 2026. Since the fund received from preferential issue has not yet been fully utilized therefore as per Regulations 32 of the SEBI (LODR) Regulations, 2015, the Company is required to file Statement of Deviation during the quarter ended 30 June 2026 in XBRL mode along with integrated financial.